557
Views
9
CrossRef citations to date
0
Altmetric
Original Articles

A Cross-Country Comparison of Reimbursed Orphan Medicines in Bulgaria, Greece and Romania

, , , &
Pages 4186-4192 | Published online: 16 Apr 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Margit Gombocz & Sabine Vogler. (2020) Public spending on orphan medicines: a review of the literature. Journal of Pharmaceutical Policy and Practice 13:1.
Read now

Articles from other publishers (8)

Maria Kamusheva & Petya Milushewa. (2021) Rare disease patients’ needs: an up-to-date analysis and future directions. Pharmacia 68:4, pages 763-770.
Crossref
Dušanka Krajnović, Jasmina Arsić, Ljiljana Tasić, Guenka Petrova & Svetlana Milijić. (2018) ACCESS TO ORPHAN DRUGS: A CROSS COUNTRY COMPARISON OF LEGISLATIVE APPROACH AMONG SERBIA, CROATI A AND MACEDONIA. Acta Medica Medianae 57:4, pages 43-51.
Crossref
Maria Kamusheva, Manoela Manova, Alexandra T. Savova, Guenka I. Petrova, Konstantin Mitov, András Harsányi, Zoltán Kaló, Kristóf Márky, Pawel Kawalec, Bistra Angelovska, Dragana Lakić, Tomas Tesar, Pero Draganic, Mary Geitona, Magdalini Hatzikou, Marian S. Paveliu & Agnes Männik. (2018) Comparative Analysis of Legislative Requirements About Patients' Access to Biotechnological Drugs for Rare Diseases in Central and Eastern European Countries. Frontiers in Pharmacology 9.
Crossref
Andreja Detiček, Igor Locatelli & Mitja Kos. (2018) Patient Access to Medicines for Rare Diseases in European Countries. Value in Health 21:5, pages 553-560.
Crossref
Patricia Vella Bonanno, Michael Ermisch, Brian Godman, Antony P. Martin, Jesper Van Den Bergh, Liudmila Bezmelnitsyna, Anna Bucsics, Francis Arickx, Alexander Bybau, Tomasz Bochenek, Marc van de Casteele, Eduardo Diogene, Irene Eriksson, Jurij Fürst, Mohamed Gad, Ieva Greičiūtė-Kuprijanov, Martin van der Graaff, Jolanta Gulbinovic, Jan Jones, Roberta Joppi, Marija Kalaba, Ott Laius, Irene Langner, Ileana Mardare, Vanda Markovic-Pekovic, Einar Magnusson, Oyvind Melien, Dmitry O. Meshkov, Guenka I. Petrova, Gisbert Selke, Catherine Sermet, Steven Simoens, Ad Schuurman, Ricardo Ramos, Jorge Rodrigues, Corinne Zara, Eva Zebedin-Brandl & Alan Haycox. (2017) Adaptive Pathways: Possible Next Steps for Payers in Preparation for Their Potential Implementation. Frontiers in Pharmacology 8.
Crossref
Todd Gammie, Christine Y. Lu & Zaheer Ud-Din Babar. (2015) Access to Orphan Drugs: A Comprehensive Review of Legislations, Regulations and Policies in 35 Countries. PLOS ONE 10:10, pages e0140002.
Crossref
Albena Zlatareva, Konstantin Tachkov, Milena Stoicheva, Svetla Georgieva, Maria Krasteva Bozhkova & Guenka Petrova. (2014) Modelling the Financial Framework of the Pharmacotherapy Cost of Rare Diseases with Orphan Medicines—Part II. Modern Economy 05:05, pages 499-505.
Crossref
Albena Zlatareva, Konstantin Tachkov, Milena Stoicheva, Svetla Georgieva, Georgi Momekov & Guenka Petrova. (2014) Financial Analysis of the Access to Pharmacotherapy for Rare Diseases in Bulgaria. Modern Economy 05:05, pages 461-467.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.